Kingsview Wealth Management, LLC Novo Cure LTD Transaction History

Kingsview Wealth Management, LLC

$4.45 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$40.29 - $82.51 $59,508 - $121,867	-1,477 Reduced 13.67%	9,326 $387,000
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $13,714 - $28,870	243 Added 2.3%	10,803 $649,000
Q4 2022 Feb 13, 2023	SELL	$63.98 - $85.37 $6,206 - $8,280	-97 Reduced 0.91%	10,560 $774,000
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $5,779 - $7,613	-85 Reduced 0.79%	10,657 $810,000
Q2 2022 Aug 16, 2022	SELL	$56.6 - $89.9 $23,602 - $37,488	-417 Reduced 3.74%	10,742 $747,000
Q1 2022 Feb 08, 2024	BUY	$60.15 - $84.52 $702,070 - $986,517	11,672 New	11,672 $967,000
Q4 2021 Feb 17, 2022	SELL	$75.08 - $121.99 $57,361 - $93,200	-764 Reduced 6.41%	11,159 $838,000
Q3 2021 Dec 03, 2021	BUY	$116.17 - $194.55 $11,849 - $19,844	102 Added 0.86%	11,923 $1.39 Million
Q2 2021 Aug 17, 2021	SELL	$130.4 - $225.58 $4,955 - $8,572	-38 Reduced 0.32%	11,821 $2.24 Million
Q1 2021 May 24, 2021	SELL	$124.11 - $190.17 $190,260 - $291,530	-1,533 Reduced 11.45%	11,859 $1.58 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $73,240 - $113,713	653 Added 5.13%	13,392 $2.32 Million
Q3 2020 Nov 19, 2020	SELL	$58.05 - $111.31 $49,342 - $94,613	-850 Reduced 6.26%	12,739 $1.42 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $336,221 - $437,381	-5,878 Reduced 30.19%	13,589 $806,000
Q1 2020 May 11, 2020	BUY	$57.05 - $95.75 $236,072 - $396,213	4,138 Added 26.99%	19,467 $1.31 Million
Q4 2019 Jan 31, 2020	BUY	$68.3 - $93.8 $1.05 Million - $1.44 Million	15,329 New	15,329 $1.29 Million
Q4 2019 Jan 30, 2020	SELL	$68.3 - $93.8 $955,175 - $1.31 Million	-13,985 Closed	0 $0
Q3 2019 Jan 29, 2020	SELL	$61.86 - $97.8 $57,529 - $90,954	-930 Reduced 6.24%	13,985 $1.05 Million
Q2 2019 Jan 29, 2020	SELL	$42.22 - $63.23 $12,032 - $18,020	-285 Reduced 1.88%	14,915 $943,000
Q1 2019 Jan 29, 2020	BUY	$31.96 - $56.12 $485,792 - $853,024	15,200 New	15,200 $732,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

76.9M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$319 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$312 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$209 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$113 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$79.8 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.

Account